Brazil supplementary health sector earns R$ 12.1 billion in H1 2026

The Brazilian supplementary health sector recorded a net profit of R$ 12.1 billion in the first half of 2026, according to data from the National Supplementary Health Agency (ANS). This figure represents a slight decrease from the R$ 12.9 billion reported during the same period in the previous year.

Medical-hospital operators, the sector's largest segment, accounted for R$ 10.9 billion of that profit, marking a 12% decline compared to the R$ 12.4 billion earned in the first half of 2025. Notable performers in the sector included Bradesco, with a net result of R$ 2.03 billion, and Amil, with R$ 960 million.

The sector's total revenue reached R$ 206.3 billion, with net profit representing approximately 5.8% of total revenue. The loss ratio (sinistralidade) for medical-hospital operators was 81.9%, a 0.8 percentage point increase from the previous year, though it remains the second lowest level recorded since 2020.

Approximately 76.2% of regulated entities reported positive net results. Additionally, financial applications by operators reached R$ 15.4 billion between April and June 2026, the highest nominal quarterly value since 2019.